KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Gross Margin (2018 - 2025)

Historic Gross Margin for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to 52.05%.

  • Twist Bioscience's Gross Margin rose 37600.0% to 52.05% in Q4 2025 from the same period last year, while for Dec 2025 it was 51.62%, marking a year-over-year increase of 70300.0%. This contributed to the annual value of 50.72% for FY2025, which is 81100.0% up from last year.
  • Per Twist Bioscience's latest filing, its Gross Margin stood at 52.05% for Q4 2025, which was up 37600.0% from 51.35% recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Gross Margin peaked at 53.4% during Q2 2025, and registered a low of 30.76% during Q1 2023.
  • Moreover, its 5-year median value for Gross Margin was 42.15% (2024), whereas its average is 42.78%.
  • Its Gross Margin has fluctuated over the past 5 years, first surged by 178900bps in 2021, then crashed by -104500bps in 2023.
  • Twist Bioscience's Gross Margin (Quarter) stood at 35.61% in 2021, then rose by 28bps to 45.72% in 2022, then dropped by -11bps to 40.51% in 2023, then increased by 19bps to 48.29% in 2024, then grew by 8bps to 52.05% in 2025.
  • Its last three reported values are 52.05% in Q4 2025, 51.35% for Q3 2025, and 53.4% during Q2 2025.